IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC).

被引：0
|
作者：
Vogel, Arndt
Siegler, Gabriele Margareta
Siebler, Jurgen
Lindig, Udo
Schultheiss, Michael
Mueller, Tobias
Simon, Henry
Joeckel, Christiane
Mueller, Daniel Wilhelm
Al-Batran, Salah-Eddin
Saborowski, Anna
De Toni, Enrico N.
机构：
[1] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[2] Paracelsus Med Univ, Klinikum Nurnberg, Med Klin 5, Hamatol Onkol, Nurnberg, Germany
[3] Univ Klinikum Erlangen, Med Klin 1, Erlangen, Germany
[4] Univ Klinikum Jena, Klin Innere Med Hamtol Onckol 2, Jena, Germany
[5] Univ Klinikum Freiburg, Klin Innere Med 2, Freiburg, Germany
[6] Charite Univ Med Berlin CVK, Med Klin Gastroenterol Infektiol & Rheumatol, Berlin, Germany
[7] Rems Murr Klinikum Winnenden, Hamatol Onkol & Palliat Med, Winnenden, Germany
[8] Inst Klin Krebsforsch IKF Krankenhaus Nordwest, Frankfurt, Germany
[9] 2Krankenhaus Nordwest, Univ Canc Ctr Frankfurt, Frankfurt, Germany
[10] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[11] LMU Munchen, Med Klin & Poliklin 2, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4107
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The efficacy and safety of toripalimab combined with sorafenib for unresectable hepatocellular carcinoma: An open-label, prospective, single-arm phase II study.
    Yang, Xin-Rong
    Cheng, Jian-Wen
    Wu, Suiyi
    Hu, Bo
    Qiu, Shuang-Jian
    Sun, Hui-Chuan
    Fan, Jia
    Zhou, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] A phase Ib/II, open-label study evaluating the efficacy and safety of Toripalimab injection (JS']JS001) or combination with Lenvatinib as a neoadjuvant therapy for patients with resectable hepatocellular carcinoma (HCC).
    Shi, Ying-Hong
    Ji, Yuan
    Liu, Wei-Ren
    Pang, Yan-Rui
    Ding, Zhen-Bin
    Fu, Xiu-Tao
    Zhang, Xin
    Huang, Cheng
    Sun, Yun-Fan
    Zhu, Xiao-Dong
    Sun, Hui-Chuan
    Zhou, Jian
    Fan, Jia
    CANCER RESEARCH, 2021, 81 (13)
  • [43] CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
    Elodie Coquan
    Pierre-Emmanuel Brachet
    Idlir Licaj
    Alexandra Leconte
    Marie Castera
    Justine Lequesne
    Emeline Meriaux
    Isabelle Bonnet
    Anais Lelaidier
    Bénédicte Clarisse
    Florence Joly
    BMC Cancer, 21
  • [44] CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
    Coquan, Elodie
    Brachet, Pierre-Emmanuel
    Licaj, Idlir
    Leconte, Alexandra
    Castera, Marie
    Lequesne, Justine
    Meriaux, Emeline
    Bonnet, Isabelle
    Lelaidier, Anais
    Clarisse, Benedicte
    Joly, Florence
    BMC CANCER, 2021, 21 (01)
  • [45] Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study
    Chen, Xiaofeng
    Li, Wei
    Wu, Xiaofeng
    Zhao, Fengjiao
    Wang, Deqiang
    Wu, Hao
    Gu, Yanhong
    Li, Xiao
    Qian, Xiaofeng
    Hu, Jun
    Li, Changxian
    Xia, Yongxiang
    Rao, Jianhua
    Dai, Xinzheng
    Shao, Qianwen
    Tang, Jie
    Li, Xiangcheng
    Shu, Yongqian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Efficacy and safety analysis of donafenib combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A prospective, single-arm, single center, phase II clinical study.
    Li, Jinpeng
    Chen, Hua
    Song, Jinlong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Updated results from venous infusion chemotherapy (VIC) plus apatinib and camrelizumab for hepatocellular carcinoma (HCC) in CNLC stage III: A prospective, single-arm, phase II trial.
    Peng, Linhui
    Chen, Tao
    Chen, Yajin
    Xu, Yunxiuxiu
    Wang, Jie
    Chen, Jie
    Li, Yong
    Huang, Pinbo
    Hu, Xiao
    Zhong, Guoping
    Chen, Xi
    Ye, Congting
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial
    Dai, Hanren
    Tong, Chuan
    Shi, Daiwei
    Chen, Meixia
    Guo, Yelei
    Chen, Deyun
    Han, Xiao
    Wang, Hua
    Wang, Yao
    Shen, Pingping
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [49] Efficacy and safety of envafolimab plus lenvatinib combined with TACE in unresectable hepatocellular carcinoma: An open-label, single-arm, phase 2 study-The CISLD-12 study.
    Liang, Tingbo
    Chen, Yiwen
    Huang, Xin
    Hu, Wendi
    Li, Xiang
    Sun, Junhui
    Shen, Yan
    Zhang, Min
    Wu, Jian
    Gao, Shunliang
    Yu, Jun
    Que, Risheng
    Zhang, Yun
    Yang, Fuchun
    Xia, Weiliang
    Zhang, Aibin
    Tang, Xiaofeng
    Bai, Xueli
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 558 - 558
  • [50] The Study of Efficacy and Safety of Robotic Stereotactic Body Radiation Therapy (SBRT) for Locally Hepatocellular Carcinoma (HCC) Patients: Midterm Results of a Multi-institutional, Single-Arm Phase 2 Trial (NCT 02363218)
    Wang, P.
    Song, Y.
    Zhang, H.
    Liang, P.
    Liu, X.
    Yuan, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S142 - S142
12345